Split History
ETFs Holding TTNP »    TTNP Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis. According to our TTNP split history records, Titan Pharmaceuticals has had 1 split.
TTNP split history picture
Titan Pharmaceuticals (TTNP) has 1 split in our TTNP split history database. The split for TTNP took place on January 25, 2019. This was a 1 for 6 reverse split, meaning for each 6 shares of TTNP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.

When a company such as Titan Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the TTNP split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Titan Pharmaceuticals shares, starting with a $10,000 purchase of TTNP, presented on a split-history-adjusted basis factoring in the complete TTNP split history. TTNP split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/03/2010
End date: 08/03/2020
Start price/share: $6.72
End price/share: $0.30
Dividends collected/share: $0.00
Total return: -95.54%
Average Annual Total Return: -26.70%
Starting investment: $10,000.00
Ending investment: $446.61
Years: 10.01
Date Ratio
01/25/20191 for 6
TTNP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TTPH Split History
UHS Split History
UNIS Split History
USPH Split History
UTHR Split History
VAR Split History
VBIV Split History
VICL Split History
VIV Split History
VIVO Split History

Also explore: TTNP shares outstanding history

Vislink Technologies, Inc. (VISL)
Grow Capital, Inc (GRWC)
Taoping Inc. (TAOP)
Atento S.A. (ATTO)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (DRIP)
Direxion Daily Dow Jones Internet Bear 3X Shares (WEBS)
Direxion Daily Consumer Discretionary Bear 3X Shares (PASS)
Direxion Daily Communication Services Index Bear 3X Shares (MUTE)
Direxion Daily Semiconductor Bear 3X Shares (SOXS)
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TTNP Insider Buying

TTNP Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.